New Arsenal of Drugs Fighting Myeloma
Progress with a growing array of investigational drugs, some of which are expected to soon be approved by the FDA, may show promise for fighting myeloma. As frequent Patient Power contributor Dr. Paul Richardson explains, the latest research shows several promising drugs and combinations with older drugs that could add effectiveness. The bottom line is more encouraging news for many people with myeloma about medicines that can extend their life with improved quality of life.
Experts & Guests
Paul Richardson, M.D.
Clinical Director, Jerome Lipper Center for Multiple Myeloma , Dana-Farber Cancer InstituteDr. Richardson is Associate Professor of Medicine at Harvard Medical School, as well as Clinical Director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston and Chairman of the American Myeloma Research Consortiom. He received his medical degree from the Medical College of St. Bartholomew's Hospital, University of London, and completed residency training at... more >